We are live on ! Find out more
HT

HAP Trading Portfolio holdings

AUM $1.42B
1-Year Est. Return 41.92%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+41.92%
3 Year Est. Return
+140.6%
5 Year Est. Return
+193.92%
10 Year Est. Return
+737.23%
AUM
$3.66B
AUM Growth
+$580M
Cap. Flow
+$878M
Cap. Flow %
24.02%
Top 10 Hldgs %
32.83%
Holding
3,064
New
672
Increased
1,002
Reduced
783
Closed
579

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$65.6M
2
W icon
Wayfair
W
+$37.1M
3
ARMK icon
Aramark
ARMK
+$28.6M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$28.1M
5
GTLB icon
GitLab
GTLB
+$26.4M

Sector Composition

Rank Sector Weight
1 Technology 6.12%
2 Healthcare 3.66%
3 Communication Services 3.55%
4 Financials 3.43%
5 Consumer Discretionary 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABEV icon
2426
PUT
Ambev
ABEV
$48.1B
$1K ﹤0.01%
+10,100
New +$28.9K
ACHR icon
2427
CALL
Archer Aviation
ACHR
$3.54B
$1K ﹤0.01%
23,100
-6,100
-21% -$40.4K
ADVM
2428
CALL
DELISTED
Adverum Biotechnologies
ADVM
$1K ﹤0.01%
2,060
-90
-4% -$1.8K
ALDX icon
2429
CALL
Aldeyra Therapeutics
ALDX
$92.9M
$1K ﹤0.01%
10,100
-39,300
-80% -$300K
BARK icon
2430
CALL
BARK
BARK
$81.8M
$1K ﹤0.01%
915
+230
+34% +$26.4K
BGSF icon
2431
CALL
BGSF Inc
BGSF
$59.5M
$1K ﹤0.01%
+12,100
New +$164K
BPMC
2432
PUT
DELISTED
Blueprint Medicines
BPMC
$1K ﹤0.01%
10,000
BTAI icon
2433
CALL
BioXcel Therapeutics
BTAI
$24.9M
$1K ﹤0.01%
+675
New +$290K
BVN icon
2434
CALL
Compañía de Minas Buenaventura
BVN
$7.69B
$1K ﹤0.01%
+12,100
New +$90.4K
CALC icon
2435
CALL
CalciMedica
CALC
$15.8M
$1K ﹤0.01%
1,800
+750
+71% +$29.1K
CMCM
2436
PUT
Cheetah Mobile
CMCM
$86.6M
$1K ﹤0.01%
+4,540
New +$34K
CNDT icon
2437
CALL
Conduent
CNDT
$244M
$1K ﹤0.01%
12,900
+2,500
+24% +$14.9K
EQH icon
2438
PUT
Equitable Holdings
EQH
$13B
$1K ﹤0.01%
10,900
FBRX icon
2439
CALL
Forte Biosciences
FBRX
$1.57B
$1K ﹤0.01%
+400
New +$26.9K
FRSX
2440
CALL
Foresight Autonomous Holdings
FRSX
$3.9M
$1K ﹤0.01%
+112
New +$35.7K
GIS icon
2441
PUT
General Mills
GIS
$19.1B
$1K ﹤0.01%
11,000
-6,400
-37% -$407K
CBIO
2442
CALL
Crescent Biopharma
CBIO
$537M
$1K ﹤0.01%
362
+29
+9% +$5.26K
GYRE icon
2443
CALL
Gyre Therapeutics
GYRE
$641M
$1K ﹤0.01%
+1,707
New +$29.2K
HST icon
2444
PUT
Host Hotels & Resorts
HST
$17.2B
$1K ﹤0.01%
15,300
-200
-1% -$3.38K
ITP icon
2445
CALL
IT Tech Packaging
ITP
$2.97M
$1K ﹤0.01%
+1,420
New +$4.78K
JAGX icon
2446
CALL
Jaguar Health
JAGX
$4.91M
0
LADR
2447
PUT
Ladder Capital
LADR
$1.21B
$1K ﹤0.01%
+12,300
New +$146K
LSTA icon
2448
CALL
Lisata Therapeutics
LSTA
$9.02M
$1K ﹤0.01%
+1,167
New +$18K
MBIO icon
2449
CALL
Mustang Bio
MBIO
$4.32M
$1K ﹤0.01%
+14
New +$22.6K
MESO
2450
CALL
Mesoblast
MESO
$1.84B
$1K ﹤0.01%
8,250
-1,100
-12% -$12.8K

Similar funds

HAP Trading's Q4 2021 Portfolio in Review

As of Q4 2021, HAP Trading held 3,064 positions worth $3.66B, up 19% from $3.08B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

HAP Trading deployed $878M of net new capital in Q4 2021, opening 672 new positions and adding to 1,002 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 543,830 shares worth $60.9M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 6.8% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Scotiabank, an estimated $14.8M trimmed.

  • HAP Trading's largest Q4 2021 buy was State Street SPDR S&P Biotech ETF: 543,830 shares worth $60.9M.
  • HAP Trading added most to Aramark in Q4 2021, an estimated $28.6M increase.
  • HAP Trading's biggest Q4 2021 reduction was Scotiabank, cutting an estimated $14.8M.
  • HAP Trading fully exited State Street SPDR S&P 500 ETF Trust in Q4 2021, selling an estimated $102M.
  • HAP Trading's ten largest holdings make up 33% of its $3.66B portfolio in Q4 2021.
  • HAP Trading opened 672 new positions and closed 579 in Q4 2021.
  • HAP Trading's portfolio value rose 19% quarter-over-quarter to $3.66B.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.